News + Filings Holdings
|
Affinity Asset Advisors, LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
MADRIGAL PHARMACEUTICALS, INC.
| MDGL | Common | 92,500 | -7,500 | 21,367,500,000 | 21,360,342,000 | | |
Hist
| 06/30/2023 |
Cerevel Therapeutics Holdings, Inc.
| CERE | Common | 550,000 | 550,000 | 17,484,500,000 | 17,484,500,000 | | |
Hist
| 06/30/2023 |
ESTABLISHMENT LABS HOLDINGS INC.
| ESTA | COM | 211,608 | -148,348 | 14,518,425,000 | 14,498,851,000 | | |
Hist
| 06/30/2023 |
CHINOOK THERAPEUTICS, INC.
| KDNY | Common | 321,017 | -616,551 | 12,333,473,000 | 12,317,075,000 | | |
Hist
| 06/30/2023 |
MADRIGAL PHARMACEUTICALS, INC.
| MDGL | CALL | 53,100 | 53,100 | 12,266,100,000 | 12,266,100,000 | | |
Hist
| 06/30/2023 |
TEVA PHARMACEUTICAL INDUSTRIES LTD
| TEVA | SPONSORED ADS | 1,600,000 | 1,600,000 | 12,048,000,000 | 12,048,000,000 | | |
Hist
| 06/30/2023 |
Morphic Holding, Inc.
| MORF | Common | 201,887 | -13,836 | 11,574,182,000 | 11,569,501,000 | | |
Hist
| 06/30/2023 |
CymaBay Therapeutics, Inc.
| CBAY | Common | 1,050,118 | -322,126 | 11,498,792,000 | 11,494,744,000 | | |
Hist
| 06/30/2023 |
BIOGEN INC.
| BIIB | Common | 40,000 | 40,000 | 11,394,000,000 | 11,394,000,000 | | |
Hist
| 06/30/2023 |
Kura Oncology, Inc.
| KURA | Common | 910,317 | -17,939 | 9,631,154,000 | 9,614,139,000 | | |
Hist
| 06/30/2023 |
Verona Pharma plc
| VRNA | SPONSORED ADS | 447,667 | 447,667 | 9,463,680,000 | 9,463,680,000 | | |
Hist
| 06/30/2023 |
Arcellx, Inc.
| ACLX | Common | 226,275 | 151,275 | 7,154,816,000 | 7,153,460,000 | | |
Hist
| 06/30/2023 |
PROTHENA CORP PUBLIC LTD CO
| PRTA | Common | 100,000 | 100,000 | 6,828,000,000 | 6,828,000,000 | | |
Hist
| 06/30/2023 |
BridgeBio Pharma, Inc.
| BBIO | Put | 376,000 | 376,000 | 6,467,200,000 | 6,467,200,000 | | |
Hist
| 06/30/2023 |
Viking Therapeutics, Inc.
| VKTX | PUT | 350,000 | 350,000 | 5,673,500,000 | 5,673,500,000 | | |
Hist
| 06/30/2023 |
Centessa Pharmaceuticals plc
| CNTA | SPONSORED ADS | 900,723 | 900,723 | 5,575,475,000 | 5,575,475,000 | | |
Hist
| 06/30/2023 |
Astria Therapeutics, Inc.
| ATXS | Common | 650,875 | 650,875 | 5,421,789,000 | 5,421,789,000 | | |
Hist
| 06/30/2023 |
Ascendis Pharma A/S
| ASND | SPONSORED ADR | 57,760 | -67,327 | 5,155,080,000 | 5,143,452,000 | | |
Hist
| 06/30/2023 |
Immunovant, Inc.
| | Common | 260,000 | 260,000 | 4,932,200,000 | 4,932,200,000 | | |
Hist
| 06/30/2023 |
Viking Therapeutics, Inc.
| VKTX | COM | 300,000 | 300,000 | 4,863,000,000 | 4,863,000,000 | | |
Hist
| 06/30/2023 |
ASTRAZENECA PLC
| AZN | SPONSORED ADR | 60,000 | -25,000 | 4,294,200,000 | 4,288,584,000 | | |
Hist
| 06/30/2023 |
Inozyme Pharma, Inc.
| INZY | Common | 751,796 | 751,796 | 4,187,504,000 | 4,187,504,000 | | |
Hist
| 06/30/2023 |
CYTOKINETICS INC
| CYTK | COM NEW | 125,148 | 110,148 | 4,082,328,000 | 4,081,739,000 | | |
Hist
| 06/30/2023 |
Autolus Therapeutics plc
| AUTL | Common | 1,589,017 | 1,589,017 | 3,781,860,000 | 3,781,860,000 | | |
Hist
| 06/30/2023 |
Immatics N.V.
| IMTX | Common | 300,000 | 300,000 | 3,462,000,000 | 3,462,000,000 | | |
Hist
| 06/30/2023 |
SpringWorks Therapeutics, Inc.
| SWTX | Common | 130,000 | 130,000 | 3,408,600,000 | 3,408,600,000 | | |
Hist
| 06/30/2023 |
Ventyx Biosciences, Inc.
| VTYX | Common | 100,696 | 100,696 | 3,302,829,000 | 3,302,829,000 | | |
Hist
| 06/30/2023 |
Viridian Therapeutics, Inc.\DE
| VRDN | Call | 130,400 | 130,400 | 3,102,216,000 | 3,102,216,000 | | |
Hist
| 06/30/2023 |
REATA PHARMACEUTICALS INC
| RETA | Common | 29,105 | 29,105 | 2,967,546,000 | 2,967,546,000 | | |
Hist
| 06/30/2023 |
Celldex Therapeutics, Inc.
| CLDX | COMMON | 87,031 | 47,031 | 2,952,962,000 | 2,951,884,000 | | |
Hist
| 06/30/2023 |
FIBROGEN INC
| FGEN | COM | 983,300 | 983,300 | 2,654,910,000 | 2,654,910,000 | | |
Hist
| 06/30/2023 |
FIBROGEN INC
| FGEN | PUT | 983,300 | 983,300 | 2,654,910,000 | 2,654,910,000 | | |
Hist
| 06/30/2023 |
Xenon Pharmaceuticals Inc.
| XENE | COM | 60,376 | 60,376 | 2,324,476,000 | 2,324,476,000 | | |
Hist
| 06/30/2023 |
Theseus Pharmaceuticals, Inc.
| THRX | Common | 240,244 | 240,244 | 2,241,477,000 | 2,241,477,000 | | |
Hist
| 06/30/2023 |
Aeglea BioTherapeutics, Inc.
| AGLE | COM | 4,900,000 | 4,900,000 | 2,207,450,000 | 2,207,450,000 | | |
Hist
| 06/30/2023 |
<< Prev Next >> |
|
|
|
|